97 related articles for article (PubMed ID: 25831148)
21. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells.
Li Y; Han W; Ni TT; Lu L; Huang M; Zhang Y; Cao H; Zhang HQ; Luo W; Li H
Oncol Rep; 2015 Jun; 33(6):2821-8. PubMed ID: 25823795
[TBL] [Abstract][Full Text] [Related]
23. Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Yin H; Xiong G; Guo S; Xu C; Xu R; Guo P; Shu D
Mol Ther; 2019 Jul; 27(7):1252-1261. PubMed ID: 31085078
[TBL] [Abstract][Full Text] [Related]
24. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
26. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
Wu N; Xiao L; Zhao X; Zhao J; Wang J; Wang F; Cao S; Lin X
FEBS Lett; 2012 Nov; 586(21):3831-9. PubMed ID: 22999819
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy.
Zhang X; Shi H; Lin S; Ba M; Cui S
Oncol Rep; 2015 Sep; 34(3):1557-64. PubMed ID: 26134156
[TBL] [Abstract][Full Text] [Related]
28. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
Zhang WC; Chin TM; Yang H; Nga ME; Lunny DP; Lim EK; Sun LL; Pang YH; Leow YN; Malusay SR; Lim PX; Lee JZ; Tan BJ; Shyh-Chang N; Lim EH; Lim WT; Tan DS; Tan EH; Tai BC; Soo RA; Tam WL; Lim B
Nat Commun; 2016 Jun; 7():11702. PubMed ID: 27325363
[TBL] [Abstract][Full Text] [Related]
29. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
31. Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.
Huang H; Hu M; Li P; Lu C; Li M
Tumour Biol; 2015 Feb; 36(2):921-8. PubMed ID: 25311946
[TBL] [Abstract][Full Text] [Related]
32. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
[TBL] [Abstract][Full Text] [Related]
33. miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
Wu T; Chen W; Kong D; Li X; Lu H; Liu S; Wang J; Du L; Kong Q; Huang X; Lu Z
Carcinogenesis; 2015 Aug; 36(8):925-35. PubMed ID: 25998847
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
35. Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 cells.
Yao Q; Sun JG; Ma H; Zhang AM; Lin S; Zhu CH; Zhang T; Chen ZT
Asian Pac J Cancer Prev; 2014; 15(1):161-6. PubMed ID: 24528019
[TBL] [Abstract][Full Text] [Related]
36. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
37. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
38. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
40. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]